Efficacy and Safety of BMS-986165 Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA)
Public ClinicalTrials.gov record NCT03881059. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Placebo-Controlled, Double-blind, Multicenter Study to Assess the Efficacy and Safety of Multiple Doses of BMS-986165 in Subjects With Active Psoriatic Arthritis (PsA)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of study is to assess the dose-response relationship of BMS-986165 (Dose A or Dose B once daily \[QD\]) at Week 16 in the treatment of participants with active PsA.
Study identification
- NCT ID
- NCT03881059
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 203 participants
Conditions and interventions
Conditions
Interventions
- BMS-986165 Placebo Other
- BMS-986165 Dose A Drug
- BMS-986165 Dose B Drug
- Ustekinumab Drug
- Ustekinumab Placebo Other
Other · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 1, 2019 (Actual)
- Primary completion
- Apr 27, 2020 (Actual)
- Completion
- Jan 27, 2021 (Actual)
- Last update posted
- Feb 15, 2022
2019 – 2021
United States locations
- U.S. sites
- 31
- U.S. states
- 18
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Rheumatology Associates of North Alabama | Huntsville | Alabama | 35801 | — |
| Medvin Clinical Research - Covina Office | Covina | California | 91722 | — |
| University of California at San Diego Medical Center | La Jolla | California | 92039 | — |
| Arthritis & Rheumatic Disease Specialties | Aventura | Florida | 33180 | — |
| San Marcus Research Clinic | Miami Lakes | Florida | 33014 | — |
| Omega Research Consultants - Metrowest | Orlando | Florida | 32835 | — |
| Integral Rheumatology & Immunology Specialists | Plantation | Florida | 33324 | — |
| BayCare Medical Group | St. Petersburg | Florida | 33705 | — |
| University of South Florida - Morsani College of Medicine | Tampa | Florida | 33612 | — |
| Heartland Research Associates - East Wichita | Wichita | Kansas | 67207 | — |
| Arthritis Center of Lexington | Lexington | Kentucky | 40504 | — |
| Clinical Pharmacology Study Group | Worcester | Massachusetts | 01605 | — |
| Arthritis Associates | Hattiesburg | Mississippi | 39402 | — |
| Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | — |
| Atlantic Coast Rheumatology | Toms River | New Jersey | 08755 | — |
| Albuquerque Center for Rheumatology | Albuquerque | New Mexico | 87102 | — |
| The Center for Rheumatology-Albany | Albany | New York | 12203 | — |
| University of Rochester Medical Center | Rochester | New York | 14642 | — |
| Joint Muscle Medical Care and Research Institute - Lilington Office | Charlotte | North Carolina | 28204 | — |
| DJL Clinical Research | Charlotte | North Carolina | 28210 | — |
| PMG Research of Salisbury | Salisbury | North Carolina | 28144 | — |
| Paramount Medical Research and Consulting | Middleburg Heights | Ohio | 44130 | — |
| East Penn Rheumatology Associates | Bethlehem | Pennsylvania | 18015 | — |
| Altoona Center for Clinical Research | Duncansville | Pennsylvania | 16635 | — |
| Low Country Rheumatology | Summerville | South Carolina | 29486 | — |
| West Tennessee Research Institute | Jackson | Tennessee | 38305 | — |
| Office of Ramesh C. Gupta, MD | Memphis | Tennessee | 38119 | — |
| Pioneer Research Solutions | Cypress | Texas | 77429-5890 | — |
| Southwest Rheumatology Research | Mesquite | Texas | 75150 | — |
| Seattle Rheumatology Associates | Seattle | Washington | 98122 | — |
| Arthritis Northwest Rheumatology | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 63 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03881059, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 15, 2022 · Synced Nov 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03881059 live on ClinicalTrials.gov.